Alvotech and Teva Set U.S. Launch Date for AVT06 Biosimilar to Eylea®
Alvotech and Teva Reach U.S. Settlement for AVT06 Alvotech and Teva have announced a settlement agreement regarding the marketing of AVT06, a proposed biosimilar to Eylea® (aflibercept), in the